Keyphrases
Schizophrenia
100%
Bipolar Disorder
92%
Denmark
49%
Antipsychotics
35%
Major Depressive Disorder
33%
Meta-analysis
32%
Healthy Controls
31%
First-episode Psychosis
29%
Schizophrenia Spectrum Disorders
29%
Randomized Controlled Trial
26%
Register Study
25%
Affective Disorders
24%
High Risk
24%
Psychiatric Disorders
23%
Antidepressants
23%
Psychosis
23%
Confidence Interval
22%
Attention Deficit Hyperactivity Disorder
21%
Systematic Meta-analysis
20%
Mental Disorders
19%
Schizophrenia Symptoms
19%
Patients with Schizophrenia
19%
Suicide
18%
Depressive Symptoms
18%
Electroconvulsive Therapy
18%
Randomized Clinical Trial
17%
Genome-wide Association Study
17%
Psychopathology
17%
Risk Factors
16%
Schizophrenic Patients
16%
Cognitive Impairment
16%
Severe Mental Illness
14%
Nationwide Registers
14%
Placebo
14%
Quality of Life
13%
Autism Spectrum Disorder
13%
Mood Disorders
12%
Family Risk
12%
Hazard Ratio
12%
Odds Ratio
12%
National Cohort Study
11%
Anorexia Nervosa
11%
Posttraumatic Stress Disorder
11%
Copenhagen
11%
Refugees
11%
Cognitive Function
11%
Negative Symptoms
10%
Functional Magnetic Resonance Imaging
10%
Incidence Rate
10%
Psychotic Disorders
10%
Nave
9%
Psychiatry
9%
Remission
9%
Suicide Risk
9%
Danish Population
9%
Suicide Attempt
9%
Autism
9%
Population-based
9%
High Resilience
9%
Polygenic Risk Score
9%
Trauma
9%
Ultra-high Risk for Psychosis
9%
Comorbidity
8%
Anxiety Disorders
8%
Suicidal Behavior
8%
Population-based Study
8%
Psychiatric Hospital
8%
Lithium
8%
Older Adults
8%
Psychotic Symptoms
8%
Mental Health
8%
COVID-19
7%
Single nucleotide Polymorphism
7%
Tourette Syndrome
7%
Mental Illness
7%
Healthy Individuals
7%
Newly Diagnosed
7%
Erythropoietin
7%
Cognitive Behavioral Therapy
7%
Unipolar Depression
7%
Ultra-high Risk
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Illness
7%
Population-based Cohort Study
7%
Randomized Placebo-controlled Trial
7%
Randomized Trial
7%
Register-based
7%
Eating Disorders
7%
Hospitalization
7%
Self-harm
7%
Dementia
7%
Danish Registers
7%
Mental Health Care
7%
Patients with Depression
7%
Treatment as Usual
6%
Hippocampus
6%
Cerebrospinal Fluid
6%
Older children
6%
Clinical Outcomes
6%
Hamilton Depression Rating Scale (HAM-D)
6%